Verma N, Burns S O, Walker L S K, Sansom D M
Clinical Immunology Department, Royal Free Hospital, London, UK.
Division of Infection and Immunity, School of Life and Medical Sciences, Institute of Immunity and Transplantation, University College London, Royal Free Hospital, London, UK.
Clin Exp Immunol. 2017 Oct;190(1):1-7. doi: 10.1111/cei.12997. Epub 2017 Jul 21.
Immune deficiency disorders are a heterogeneous group of diseases of variable genetic aetiology. While the hallmark of immunodeficiency is susceptibility to infection, it is increasingly clear that autoimmunity is prevalent, suggestive of a more general immune dysregulation in some cases. With the increasing use of genetic technologies, the underlying causes of immune dysregulation are beginning to emerge. Here we provide a review of the heterozygous mutations found in the immune checkpoint protein CTLA-4, identified in cases of common variable immunodeficiency disorders (CVID) with accompanying autoimmunity. Study of these mutations provides insights into the biology of CTLA-4 as well as suggesting approaches for rational treatment of these patients.
免疫缺陷疾病是一组病因各异的遗传性疾病。虽然免疫缺陷的标志是易受感染,但越来越明显的是,自身免疫现象普遍存在,这表明在某些情况下存在更普遍的免疫失调。随着基因技术的日益应用,免疫失调的潜在原因开始显现。在此,我们综述了在伴有自身免疫的常见可变免疫缺陷疾病(CVID)病例中发现的免疫检查点蛋白CTLA-4中的杂合突变。对这些突变的研究为CTLA-4的生物学特性提供了见解,并为合理治疗这些患者提出了方法。